William A. Wexler's most recent trade in Eterna Therapeutics Inc was a trade of 124,533 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eterna Therapeutics Inc | William A. Wexler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 124,533 | 124,533 | - | - | Stock Option (right to buy) | |
| Comera Life Sciences Holdings | William A. Wexler | Director | Other type of transaction at price $ 0.00 per share. | 11 Aug 2023 | 6,636 | 17,698 | - | 0 | Common Stock | |
| Comera Life Sciences Holdings | William A. Wexler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 27,472 | 27,472 | - | - | Stock Option (Right to Purchase) | |
| Comera Life Sciences Holdings | William A. Wexler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 7,100 | 7,100 | - | - | Stock Option (Right to Purchase) | |
| Comera Life Sciences Holdings | William A. Wexler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 14,200 | 14,200 | - | - | Stock Option (Right to Purchase) | |
| Eterna Therapeutics Inc | William A. Wexler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 165,800 | 165,800 | - | - | Stock Option (right to buy) | |
| Eterna Therapeutics Inc | William A. Wexler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 152,100 | 152,100 | - | - | Stock Option (right to buy) |